All News #Library
Others
Star Therapeutics Presents Data For VGA039 Therapy for Von Willebrand Disease
26 Jun 2024 //
BUSINESSWIRE
Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer
03 Jan 2024 //
BUSINESSWIRE
Star Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 //
BUSINESSWIRE
Star Appoints Matthew Fust as Independent Director and Board Audit Chair
05 Dec 2023 //
BUSINESSWIRE
Star Therapeutics Raises $90 Million Financing
05 Sep 2023 //
BUSINESSWIRE

Market Place
Sourcing Support